한국간담췌외과학회지 (Annals of Hepato-Biliary-Pancreatic Surgery)

  • 제13권4호
  • /
  • Pages.242-250
  • /
  • 2009
  • /
  • 2508-5778(pISSN)
  • /
  • 2508-5859(eISSN)
한국간담췌외과학회 (The Korean Association of Hepato-Biliary-Pancreatic Surgery)
권호 표지

비장동맥 차단술이 생체간이식 수술 수혜자의 전혈구 수치 변화에 미치는 영향

Effect of Splenic Artery Interruption on Complete Blood Count Profiles in Living Donor Liver Transplant Recipients

  • 김완준 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 문덕복 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 박정익 (인제대학교 의과대학 부산백병원 외과학교실) ;
  • 황신 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 김기훈 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 안철수 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 하태용 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 송기원 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 정동환 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 김관우 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 최남규 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 박길춘 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 유영동 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 박평재 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 최영일 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실) ;
  • 최건무 (울산대학교 의과대학 강릉아산병원 외과학교실) ;
  • 이승규 (울산대학교 의과대학 서울아산병원 간담도 및 간이식외과학교실)
  • Kim, Wan-Joon (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Moon, Deok-Bog (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Jeong-Ik (Department of Surgery, Busan Paik Hospital, Inje University College of Medicine) ;
  • Hwang, Shin (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Ki-Hun (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ahn, Chul-Soo (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ha, Tae-Yong (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Song, Gi-Won (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jung, Dong-Hwan (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Kwan-Woo (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Nam-Kyu (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Gil-Chun (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Yu, Young-Dong (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Pyung-Jae (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Young-Il (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Kun-Moo (Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine) ;
  • Lee, Sung-Gyu (Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • 발행 : 2009.12.31

⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: Splenectomy during living donor liver transplantation (LDLT) in a hepatitis C virus (HCV)-related cirrhotic recipient was performed by a Tokyo group to enhance the patient's tolerability to post-operative anti-viral treatment by improving complete blood count (CBC) profiles. At our institution, interruption of the splenic artery (SPA) by ligation or embolization in lieu of splenectomy, has been performed in LDLT to modulate portal blood flow in small-for-size graft LDLT or to prevent rupture of SPA aneurysms in recipients. We aimed to determine if interruption of the SPA can serve as an alternative management to splenectomy in LDLT recipients based on our data. Methods: Patients were classified into the splenic artery ligation group (SAL; n=26) and splenic artery embolization group (SAE; n=19), respectively. Among the recipients without SPA interruption, age-, gender-, and severity of cirrhosis-matched 25 recipients were selected as a control group. Post-operative CBC profiles and spleen size were reviewed retrospectively and compared between the groups. Results: After SAL, platelet and neutrophil counts were significantly increased at 3 and 6 months, and at 1 week and 1 month, respectively (p<0.05). After SAE, platelet and neutrophil counts were significantly increased at 3 and 6 months, and at 1 week and 3 months, respectively. There were no significant complications related to interruption of the SPA. Conclusion: Interruption of the SPA may have a role in improving neutrophil and platelet counts in LDLT recipients with severe pancytopenia or in whom antiviral treatment for HCV in anticipated.

키워드

참고문헌

  1. N'Kontchou G, Seror O, Bourcier V, et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol 2005;17:179-184. https://doi.org/10.1097/00042737-200502000-00008
  2. Lisman T, Leebeek FW, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol 2002;37: 280-287. https://doi.org/10.1016/S0168-8278(02)00199-X
  3. Berenguer M, Palau A, Feranandez A, et al. Efficacy, predictors of response and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2006;12:1067-1076. https://doi.org/10.1002/lt.20737
  4. Neumann U, Puhl G, Bahara M, et al. Treatment of patients with recurrent heaptitis C after liver transplantaiton with peginterferon alfa-2b plus ribavirin. Transplantation 2006;82: 43-47. https://doi.org/10.1097/01.tp.0000225827.18034.be
  5. Lee CM, Leung TK, Wang HJ, et al. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastroenterol 2007;13:619-622. https://doi.org/10.3748/wjg.v13.i4.619
  6. Xu RY, Liu B, Lin N. Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension. World J Gastoroenterol 2004;10:1072- 1074. https://doi.org/10.3748/wjg.v10.i7.1072
  7. Kishi Y, Sugawara Y, Akamatsu N, et al. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin Transplant 2005;19: 769-772. https://doi.org/10.1111/j.1399-0012.2005.00419.x
  8. McCormick PA, Murphy KM. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Baillieres Clin Gastroenterol 2000;14:1009-1031. https://doi.org/10.1053/bega.2000.0144
  9. Sakai T, Shiraki K, Inoue H, et al. Complications of partial splenic embolization in cirrhotic patients. Dig Dis Sci 2002; 47:388-391. https://doi.org/10.1023/A:1013786509418
  10. Maddison FE. Embolic therapy of hypersplenism. Invest Radiol 1973;8:280-281.
  11. Mozes MF, Spigos DG, Pollak R, et al. Partial splenic embolization, an alternative to splenectomy--results of a prospective, randomized study. Surgery 1984;96:694-702.
  12. Shah R, Mahour GH, Ford EG, Stanley P. Partial splenic embolization. An effective alternative to splenectomy for hypersplenism. Am Surg 1990;56:774-777.
  13. Umeda Y, Yagi T, Sadamori H, et al. Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in smll-for-size graft. Transplantation 2008;86: 673-680.
  14. Heestand G, Sher L, Lightfoote J, et al. Characteristics and management of splenic artery aneurysm in liver transplant candidates and recipients. Am Surg 2003;69:933-940.
  15. Moon DB, Lee SG, Hwang S, et al. Characteristics and management of splenic artery aneurysms in adult living donor liver transplant recipients. Liver Transpl 2009;15:1535-1541. https://doi.org/10.1002/lt.21885
  16. Matsukura A, Kita Y, Harihara Y, et al. Is splenic artery ligation effective for thrombocytopenia early after liver transplantation? Transpl Proc 1999;31:2906-2907. https://doi.org/10.1016/S0041-1345(99)00610-7
  17. Gane E. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transpl 2003;9:S28-34. https://doi.org/10.1053/jlts.2003.50248
  18. Sugawara Y, Makuuchi M. Living donor liver transplantation to patients with hepatitis C virus cirrhosis. World J Gastroenterol 2006;12:4461-4465. https://doi.org/10.3748/wjg.v12.i28.4461
  19. Berenguer M. Lopez-labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001;35:666-678. https://doi.org/10.1016/S0168-8278(01)00179-9
  20. Rodriguez-Luna H, Khatib A, Sharma P, et al. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha-2b and ribavirin: an open-label series. Transplantation 2004;77:190-194. https://doi.org/10.1097/01.TP.0000100481.14514.BB
  21. Park JI, Choi KM, Lee SG, et al. Clinical outcome after living donor liver transplantation in patients with hepatitis C virusassociated cirrhosis. Korean J Hepatol 2007;13:543-555. https://doi.org/10.3350/kjhep.2007.13.4.543
  22. Barcena R, Gil-Grande L, Moreno J, et al. Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin. Transplantation 2005;79:1634- 1635. https://doi.org/10.1097/01.TP.0000155424.52939.3D
  23. Romano M, Giojelli A, Capuano G, Pomponi D, Salvatore M. Partial splenic embolization in patients with idiopathic portal hypertension. Eur J Radiol 2004;49:268-273. https://doi.org/10.1016/S0720-048X(03)00134-7
  24. Palsson B, Hallen M, Forsberg AM, Alwmark A. Partial splenic embolization: long-term outcome. Langenbecks Arch Surg 2003;387:421-426.